American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Abdel-Wahab
    Abdel-Wahab
  10. Kernan
    Kernan

Groups

  1. Department of Medicine (3908)
  2. Hematologic Malignancies, Division of (3707)
  3. Center for Hematologic Malignancies (3597)
  4. GSK Faculty (1574)
  5. Adult Leukemia (1313)
  6. Sloan Kettering Institute Faculty (1069)
  7. Bone Marrow Transplant (952)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (945)
  9. Lymphoma (913)
  10. Tow Center for Developmental Oncology (TCDO) (872)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3908)
  2. Hematologic Malignancies, Division of (3707)
  3. Center for Hematologic Malignancies (3597)
  4. GSK Faculty (1574)
  5. Adult Leukemia (1313)
  6. Sloan Kettering Institute Faculty (1069)

More Groups

People
  1. Sergio Giralt (339)
  2. Andrew Zelenetz (336)
  3. Ross Levine (315)
  4. Martin Tallman (300)
  5. Miguel-Angel Perales (298)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5165)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5537)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The combination of ATRA and dasatinib for differentiation therapy in acute myeloid leukemias with IDH mutations
    Meeting Abstract

    Boutzen, H.; Saland, E.; Cathebras, M.; Larrue, C.; Farge, T.; Serhan, N.; De Toni, F.; David, M.; Gales, L.; Castelli, F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk factors and a prognostic score for progression free survival after treatment with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory Hodgkin lymphoma (rrHL)
    Meeting Abstract

    BroĢˆckelmann, P. J.; Muller, H.; Casasnovas, O.; Hutchings, M.; von Tresckow, B.; Borchmann, P.; Moskowitz, C.; Engert, A.
    Blood (2015)

    Fulltext@MSK | Save
  • Patterns of lymphocytosis in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) treated with idelalisib
    Meeting Abstract

    Brown, J. R.; Cheson, B. D.; Furman, R. R.; Ghia, P.; Hallek, M.; Hillmen, P.; O'Brien, S. M.; Sharman, J. P.; Dubowy, R. L.; Velasco, B.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Differences in patients with progressive versus non-progressive AML, CLL, or NHL: Implications for proposed bundled payment strategies
    Meeting Abstract

    Byfield, S. D.; Engel-Nitz, N.; Bancroft, T.; Anderson, A. J.; Reyes, C.; Ravelo, A.; Ogale, S.; Chen, M.; Matasar, M. J.
    Blood (2015)

    Fulltext@MSK | Save
  • A therapeutic TCR mimic monoclonal antibody for intracellular PRAME protein in leukemias
    Meeting Abstract

    Chang, A.; Dao, T.; Scott, A.; Dubrovsky, L.; Liu, C.; Scheinberg, D. A.
    Blood (2015)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
    Meeting Abstract

    Cheah, C. Y.; Broeckelmann, P. J.; Moskowitz, A. J.; Engert, A.; Jerkeman, M.; El-Galaly, T. C.; Vose, J.; Villa, D.; Connors, J. M.; Feldman, T.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Phase 2 study of carfilzomib (CFZ) with or without filanesib (FIL) in patients with advanced multiple myeloma (MM)
    Meeting Abstract

    Zonder, J. A.; Usmani, S.; Scott, E. C.; Hofmeister, C. C.; Lendvai, N.; Berdeja, J. C.; Anderson, L. D.; Hari, P.; Singhal, S.; Orloff, G.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Patient characteristics and early death predictors in acute promyelocytic leukaemia patients; Experience from United Arab Emirates (UAE)
    Meeting Abstract

    Alzaabi, M. R.; Hassan, I. B.; Tallman, M. S.; Alam, A.; Al Qawasmeh, K.; Kristensen, J.
    Blood (2015)

    Fulltext@MSK | Save
  • Distinctive genomic alterations in testicular diffuse large B cell lymphoma
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Wang, L.; Intlekofer, A. M.; Copeland, A. R.; Jungbluth, A. A.; Reiner, A.; Pichardo, J. D.; Gallagher, M.; Bouvier, N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save